Trial Profile
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Sep 2005 New trial record.